Earnings Snapshot: Bionano Genomics sees Q4, FY25 revenue below analysts' consensus
Source: SeekingAlpha
2025-11-13 16:33:10 ET
More on Bionano Genomics
- Bionano Genomics, Inc. (BNGO) Presents At H.C. Wainwright 27th Annual Global Investment Conference Prepared Remarks Transcript
- Bionano Genomics reports Q3 results
- Bionano Genomics Q3 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Bionano Genomics
- Historical earnings data for Bionano Genomics
Read the full article on Seeking Alpha
For further details see:
Earnings Snapshot: Bionano Genomics sees Q4, FY25 revenue below analysts' consensus
Bionano Genomics Inc.
NASDAQ: BNGO
BNGO Trading
-1.72% G/L:
$1.15 Last:
239,973 Volume:
$1.15 Open:
BNGO Latest News
March 23, 2026 04:05:00 pm
Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026
BNGO Stock Data
$12,206,112
10,084,416
0.03%
11
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
